搜档网
当前位置:搜档网 › Trials and Tribulations of

Trials and Tribulations of

the participants agreed or strongly agreed that the time spent on simulation activities can be of great value,bearing in mind the80-hour work week restrictions.Up to75%of residents agreed or strongly agreed that previous simulation encoun-ters have enhanced their communication,decision making,and teamwork skills,in addition to their patient care and patient safety skills(Table).On the other hand,almost50%of residents dis-agreed or strongly disagreed that the Accredita-tion Council for Graduate Medical Education (ACGME)should mandate the integration of simulation curricula in surgical residency pro-grams.Similarly,almost half the residents did not believe that new technologies should be tested first in a simulated setting,before their use is warranted in clinical medical practice. Several interesting themes emerged from the group discussions.Concern was raised regarding the lack of evidence for efficacy,the use of non-validated teaching methods,and the feasibility and fidelity of currently available simulation models.Some participants believed the educa-tional significance of simulation to be inversely proportional to the level of training,meaning that novices may benefit more from this tool compared to experts.There were also concerns regarding the influence of external forces(public pressure and regulatory institutions)on the direction of simulation training.On the other hand,positive feedback regarding simulation was also noted during these discussions.The benefit of technical skill acquisition in a safe and stress-free learning environment was emphasized.Some participants identified simulation as a preparative training tool that could be useful prior to performing tasks on real patients.While a group of residents regarded simulation as an educational tool that might allow for the acquisition of technical proficiency,the majority agreed that it could not replace training on real patients.

In this survey,Wehbe-Janek et al tabulated interesting resident insights on surgical simula-tion.On one hand,it appears that there is a strong consensus that simulation is an impor-tant element in surgical education amongst surgical residents.On the other,it is clear that much work remains to be done in the areas of validation and simulation fidelity,as well as in making simulation relevant to more advanced levels of training.This report suggests that residents desire robust education but are leary of excessive regulatory oversight.

While the value of simulation becomes increas-ingly apparent in surgical education,its imple-mentation remains inconsistent.An important factor in implementing a simulation curriculum is resident buy-in.Without this,simulators will be left to collect dust.The work by Wehbe-Janek et al sheds light on general surgery resident perspectives

which provides our field of neurosurgery with

surrogate data that can be used as simulation

approaches are designed and implemented.Care-

ful attention to resident feedback will likely be an

important element of success,as simulation

curricula come on line in neurosurgery training

programs.We suspect that residency training

programs that emphasize thoughtful and validated

simulation training may gain a competitive edge in

Neurosurgical education.

T AREK Y.E L A HMADIEH

N AJIB E.E L T ECLE

S ALAH G.A OUN

B YRON K.Y IP

A RUNA G ANJU

B ERNARD R.B ENDOK

REFERENCES

1.Satava RM.Emerging trends that herald the future of

surgical simulation.Surg Clin North Am.2010;90(3):

623-633.

2.Philibert I,Friedmann P,Williams WT.New

requirements for resident duty hours.JAMA.2002;

288(9):1112-1114.

3.Fargen KM,Chakraborty A,Friedman WA.Results of

a national neurosurgery resident survey on duty hour

regulations.Neurosurgery.2011;69(6):1162-1170.

4.Cosman P,Hemli JM,Ellis AM,Hugh TJ.Learning

the surgical craft:a review of skills training options.

ANZ J Surg.2007;77(10):838-845.

5.Stefanidis D,Arora S,Parrack DM,et al.Research

priorities in surgical simulation for the21st century.

Am J Surg.2012;203(1):49-53.

6.Wehbe-Janek H,Colbert CY,Govednik-Horny C,

White BA,Thomas S,Shabahang M.Residents’

perspectives of the value of a simulation curriculum in

a general surgery residency program:a multimethod

study of stakeholder feedback.Surgery.2012;151(6):

815-821.

Trials and Tribulations of

Cancer Immunotherapy:

The Dendritic Cell

Vaccine Shows Promise in

a Phase I Glioblastoma

Multiforme Trial

S ince the publication7years ago of the

landmark paper by Stupp et al survival of

glioblastoma multiforme(GBM)has

reached a plateau,with only limited non-significant

increases in survival.1Despite the most aggres-

sive therapies this devastating malignancy has

a near perfect recurrence rate,accounting for

nearly15%of all brain tumors in adults

between the ages of45and70.2Over the last

few decades however,great strides have been

made in cancer immunotherapy,most notably

with the creation of the human papilloma virus

(HPV)vaccine for cervical cancer,and T-cell

therapies for advanced melanoma.3A short-

coming to these therapies is that they require

the cultivation of substantial amounts of lym-

phocytes using uncommon technical expertise

and facilities.3Less labor-intensive immuno-

therapy modalities like vaccines may prove

more efficacious.

Dendritic cells(DCs)theoretically are a prime

candidate for cancer vaccines.Specifically,they

are known to be the most powerful antigen-

presenting cells(APCs)and are largely responsible

for the initial sensitization of na?ve T-cells to

antigens.Plus they are present in nearly all sites of

pathogen entry.4Thus it seemed reasonable to

harness the power of these cells to achieve the

strongest immunity.Furthermore,DCs can be

derived ex vivo from blood monocytes exposed to

granulocyte-macrophage colony-stimulating fac-

tor(GM-CSF)and interleukin-4(IL-4).5DC

immunotherapy and vaccination has been stud-

ied in a wide variety of cancers,Phuphanich et al

have recently reported the results of a phase I

clinical trial in which patient-derived DCs were

pulsed with multiple tumor-associated antigens

(TAAs)that are expressed on gliomas and known

to be overexpressed in the cancer stem cell(CSC)

population.6

Patients with newly diagnosed or recurrent

GBM who underwent a gross total resection and

were HLA-A1and/or A-2positive were enrolled.

A well understood mechanism for tumors to

avoid immune detection and eradication is

through minimizing the presentation of antigens

to class I major histocompatability complexes

(MHCs).This failure has been partly traced to

mutations and deletions affecting the expression

of human leukocyte antigen(HLA)molecules.7-10

The autologous DC vaccine was prepared from

monocytes obtained through leukapheresis and

cultured ex vivo.To target the DCs to the CSC

population HLA-1restricted TAA’s MAGE1

and AIM-2,and HLA-2restricted TRP-2,

gp100,HER2,and IL13Ra2were pulsed for

16to20hours.Subsequently,sterility was

tested and patients were then given3injections

of the vaccine,and monitored for adverse events

(AE).

Upon analysis of the expression of the TAA’s

targeted by the vaccine,it was shown that

expression of the HLA-1restricted TAA’s

significantly correlated with progression-free

survival(PFS)and overall survival(OS).Addi-

tionally,the expression of HER2and gp100

appeared to exhibit a trend towards longer PFS

NEURO SURGERY VOLUME71|NUMBER6|DECEMBER2012|N19

and OS.In response to vaccine administration, A2epitopes showed significant downregulation (P?.023;Fisher’s exact test)relative to upregulation in3patients where responses were https://www.sodocs.net/doc/6a2868128.html,paratively,the downregulation A1epitope AIM2was not significant yielded a P value of.21(Fisher’s exact test).

The characterization of GBM CSCs has lead to the defining surface marker of this putative cell population:CD133.Cells expressing this marker(CD1331)have been shown to be more resistant to radiation11and chemother-apy,12and be correlated to a poor clinical outcome.6Moreover,CD133positivity has

been reported to increase in recurrence,possibly

owing to the severity and rapid clinical degra-

dation.Intriguingly,the vaccine illustrated

a preferential targeting of CD133positive cells.

Previous studies by this group and others have

consistently shown increased CD133in recur-

rent tumors,especially in recurrent tumors even

after TAA loaded DC vaccination.6In newly

diagnosed and recurrent patients,the CD133

expression was shown to markedly decrease

with1recurrent and1newly diagnosed patient

becoming CD133negative.

Analysis of immune responses7days before

vaccine administration compared to samples

obtained56days after the first vaccine admin-

istration showed a33%positive vaccine

response of..5-fold increase.PFS and OS

and long-term survivors exhibiting increasing

trends towards better survival,however they

were not significant.At a median follow-up of

40.1months,6of the16newly diagnosed

patients showed no evidence of tumor recur-

rence.Median PFS and OS in the newly

diagnosed patients were16.9months and38.4

months respectively.

Figure1.Schema of treatment schedule and events(A)The correlation of quantitative antigen expression on primary tumor from new diagnosed patients(n?13)with progression-free survival(PFS;left set of6graphs)and overall survival(OS;right set of6graphs).Logarithmic plots of antigen expression were determined by qRT-PCR.A significant correlation between HLA-1antigens and PFS and OS was observed while gp100and HER2antigens trended towards a positive correlation in both PFS and OS.(B)Kaplan-Meier estimates of PFS(left panel)and OS(right panel)for newly diagnosed patients(n?16)(Dotted line illustrates95%CI;hash marks are for censored patients.)(C)CD133 expression by RT-PCR in primary tumor and subsequent tumor samples from newly diagnosed and recurrent patients.Expression is calculated relative to GADPH.CD133 expression was negative or decreased in subsequently after vaccine administration(D).With kind permission from Springer Science1Business Media:Cancer Immunology Immunotherapy,Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma,2012Jul31.[Epub ahead of print].

N20|VOLUME71|NUMBER6|https://www.sodocs.net/doc/6a2868128.html,

Despite these median survival times being comparable to current survival,the ICT-107 vaccine illustrated an impressive percent of res-ponders,exhibiting an increased immune res-ponse,33%,higher than recent immunotherapy vaccines trials.A central problem in developing cancer vaccines is that all immunotherapies, vaccines included,are dependent on their ability to generate immune responses to specific and defined targets that must be presented by the tumor cells.Historically this has been the great-est challenge in creating novel vaccines.The immunoediting hypothesis13may partly help to explain the limited success of recent cancer vaccines,and the difficulty in targeting tumor cells.Furthermore,the full potential of den-dritic cells may not have been fully exploited or the hypothesis that DCs are not an effective pathway to pursue may hold true.

Careful re-evaluation of current vaccine design is crucial;the natural course of DCs and their role in the immune system all must be taken into account.Equally important,soluble factors such as IL-12must be considered particularly for their immuno-modulating capabilities.3Finally, clinical trials need to incorporate validated prognostic methods(eg,delayed-type hyper-sensitivity responses,T-cell cytotoxicity assay) to monitor anticancer immune activity in vivo as an intermediary measure of efficacy.4The notion of inducing the body to fight the human body,the central notion of the immune system, works for the copious other maladies that affect the human condition.Advances in our under-standing of neuroimmunology will greatly increase our efficacy with cancer vaccines and reverberate in rational vaccine development, clinical trial designs,and analyses.

D EMIRKAN B.GüRSEL

C ODY D.S CHLAFF

J OHN A.B OOCKVAR REFERENCES

1.Stupp R,Mason WP,van den Bent MJ,et al.

Radiotherapy plus concomitant and adjuvant temo-zolomide for glioblastoma.N Engl J Med.2005;352

(10):987-996.

2.DeVita VT,Hellman S,Rosenberg SA.Cancer,

Principles and Practice of Oncology.Philadelphia,PA: Lippincott,Williams&Wilkins;2001.

3.Koski GK,Cohen PA,Roses RE,Xu S,Czerniecki BJ.

Reengineering dendritic cell-based anti-cancer vac-cines.Immunol Rev.2008;222:256-276.

4.Yong RL,Lonser RR.Immunotherapy trials for

glioblastoma multiforme:promise and pitfalls.World Neurosurg.2012;77(5-6):636-638.

5.Schuler G.Dendritic cells in cancer immunotherapy.

Eur J Immunol.2010;40(8):2123-2130.

6.Phuphanich S,Wheeler CJ,Rudnick JD,et al.Phase I

trial of a multi-epitope-pulsed dendritic cell vaccine

for patients with newly diagnosed glioblastoma

[published online ahead of print].Cancer Immunol

Immunother.2012.

7.Hicklin DJ,Wang Z,Arienti F,Rivoltini L,Parmiani G,

Ferrone S.beta2-Microglobulin mutations,HLA class I

antigen loss,and tumor progression in melanoma.J Clin

Invest.1998;101(12):2720-2729.

8.Meissner M,Reichert TE,Kunkel M,et al.Defects in

the human leukocyte antigen class I antigen process-

ing machinery in head and neck squamous cell

carcinoma:association with clinical outcome.Clin

Cancer Res.2005;11(7):2552-2560.

9.Vitale M,Rezzani R,Rodella L,et al.HLA class I

antigen and transporter associated with antigen

processing(TAP1and TAP2)down-regulation in

high-grade primary breast carcinoma lesions.Cancer

Res.1998;58(4):737-742.

10.Wang Z,Marincola FM,Rivoltini L,Parmiani G,

Ferrone S.Selective histocompatibility leukocyte

antigen(HLA)-A2loss caused by aberrant pre-mRNA

splicing in624MEL28melanoma cells.J Exp Med.

1999;190(2):205-215.

11.Bao S,Wu Q,McLendon RE,et al.Glioma stem

cells promote radioresistance by preferential activa-

tion of the DNA damage response.Nature.2006;

444(7120):756-760.

12.Liu G,Yuan X,Zeng Z,et al.Analysis of gene

expression and chemoresistance of CD1331cancer

stem cells in glioblastoma.Mol Cancer.2006;5:67.

13.Dunn GP,Fecci PE,Curry WT.Cancer immunoe-

diting in malignant glioma.Neurosurgery.2012;71

(2):201-223.

Granulocyte-stimulating

Colony Factor

Neuroprotection for

Thoracic Myelopathy

G ranulocyte-stimulating colony factor

(G-CSF),commercially available as

Neupogen or Neulasta,has long been

used for the treatment of neutropenia in cancer

patients.Several clinical studies have examined

the utility of G-CSF in amyotrophic lateral

sclerosis and ischemic stroke,with ambiguous,

NEURO SURGERY VOLUME71|NUMBER6|DECEMBER2012|N21

如何写先进个人事迹

如何写先进个人事迹 篇一:如何写先进事迹材料 如何写先进事迹材料 一般有两种情况:一是先进个人,如先进工作者、优秀党员、劳动模范等;一是先进集体或先进单位,如先进党支部、先进车间或科室,抗洪抢险先进集体等。无论是先进个人还是先进集体,他们的先进事迹,内容各不相同,因此要整理材料,不可能固定一个模式。一般来说,可大体从以下方面进行整理。 (1)要拟定恰当的标题。先进事迹材料的标题,有两部分内容必不可少,一是要写明先进个人姓名和先进集体的名称,使人一眼便看出是哪个人或哪个集体、哪个单位的先进事迹。二是要概括标明先进事迹的主要内容或材料的用途。例如《王鬃同志端正党风的先进事迹》、《关于评选张鬃同志为全国新长征突击手的材料》、《关于评选鬃处党支部为省直机关先进党支部的材料》等。 (2)正文。正文的开头,要写明先进个人的简要情况,包括:姓名、性别、年龄、工作单位、职务、是否党团员等。此外,还要写明有关单位准备授予他(她)什么荣誉称号,或给予哪种形式的奖励。对先进集体、先进单位,要根据其先进事迹的主要内容,寥寥数语即应写明,不须用更多的文字。 然后,要写先进人物或先进集体的主要事迹。这部分内容是全篇材料

的主体,要下功夫写好,关键是要写得既具体,又不繁琐;既概括,又不抽象;既生动形象,又很实在。总之,就是要写得很有说服力,让人一看便可得出够得上先进的结论。比如,写一位端正党风先进人物的事迹材料,就应当着重写这位同志在发扬党的优良传统和作风方面都有哪些突出的先进事迹,在同不正之风作斗争中有哪些突出的表现。又如,写一位搞改革的先进人物的事迹材料,就应当着力写这位同志是从哪些方面进行改革的,已经取得了哪些突出的成果,特别是改革前后的.经济效益或社会效益都有了哪些明显的变化。在写这些先进事迹时,无论是先进个人还是先进集体的,都应选取那些具有代表性的具体事实来说明。必要时还可运用一些数字,以增强先进事迹材料的说服力。 为了使先进事迹的内容眉目清晰、更加条理化,在文字表述上还可分成若干自然段来写,特别是对那些涉及较多方面的先进事迹材料,采取这种写法尤为必要。如果将各方面内容材料都混在一起,是不易写明的。在分段写时,最好在每段之前根据内容标出小标题,或以明确的观点加以概括,使标题或观点与内容浑然一体。 最后,是先进事迹材料的署名。一般说,整理先进个人和先进集体的材料,都是以本级组织或上级组织的名义;是代表组织意见的。因此,材料整理完后,应经有关领导同志审定,以相应一级组织正式署名上报。这类材料不宜以个人名义署名。 写作典型经验材料-般包括以下几部分: (1)标题。有多种写法,通常是把典型经验高度集中地概括出来,一

关于时间管理的英语作文 manage time

How to manage time Time treats everyone fairly that we all have 24 hours per day. Some of us are capable to make good use of time while some find it hard to do so. Knowing how to manage them is essential in our life. Take myself as an example. When I was still a senior high student, I was fully occupied with my studies. Therefore, I hardly had spare time to have fun or develop my hobbies. But things were changed after I entered university. I got more free time than ever before. But ironically, I found it difficult to adjust this kind of brand-new school life and there was no such thing called time management on my mind. It was not until the second year that I realized I had wasted my whole year doing nothing. I could have taken up a Spanish course. I could have read ten books about the stories of successful people. I could have applied for a part-time job to earn some working experiences. B ut I didn’t spend my time on any of them. I felt guilty whenever I looked back to the moments that I just sat around doing nothing. It’s said that better late than never. At least I had the consciousness that I should stop wasting my time. Making up my mind is the first step for me to learn to manage my time. Next, I wrote a timetable, setting some targets that I had to finish each day. For instance, on Monday, I must read two pieces of news and review all the lessons that I have learnt on that day. By the way, the daily plan that I made was flexible. If there’s something unexpected that I had to finish first, I would reduce the time for resting or delay my target to the next day. Also, I would try to achieve those targets ahead of time that I planed so that I could reserve some more time to relax or do something out of my plan. At the beginning, it’s kind of difficult to s tick to the plan. But as time went by, having a plan for time in advance became a part of my life. At the same time, I gradually became a well-organized person. Now I’ve grasped the time management skill and I’m able to use my time efficiently.

脐带干细胞综述

脐带间充质干细胞的研究进展 间充质干细胞(mesenchymal stem cells,MSC S )是来源于发育早期中胚层 的一类多能干细胞[1-5],MSC S 由于它的自我更新和多项分化潜能,而具有巨大的 治疗价值 ,日益受到关注。MSC S 有以下特点:(1)多向分化潜能,在适当的诱导条件下可分化为肌细胞[2]、成骨细胞[3、4]、脂肪细胞、神经细胞[9]、肝细胞[6]、心肌细胞[10]和表皮细胞[11, 12];(2)通过分泌可溶性因子和转分化促进创面愈合;(3) 免疫调控功能,骨髓源(bone marrow )MSC S 表达MHC-I类分子,不表达MHC-II 类分子,不表达CD80、CD86、CD40等协同刺激分子,体外抑制混合淋巴细胞反应,体内诱导免疫耐受[11, 15],在预防和治疗移植物抗宿主病、诱导器官移植免疫耐受等领域有较好的应用前景;(4)连续传代培养和冷冻保存后仍具有多向分化潜能,可作为理想的种子细胞用于组织工程和细胞替代治疗。1974年Friedenstein [16] 首先证明了骨髓中存在MSC S ,以后的研究证明MSC S 不仅存在于骨髓中,也存在 于其他一些组织与器官的间质中:如外周血[17],脐血[5],松质骨[1, 18],脂肪组织[1],滑膜[18]和脐带。在所有这些来源中,脐血(umbilical cord blood)和脐带(umbilical cord)是MSC S 最理想的来源,因为它们可以通过非侵入性手段容易获 得,并且病毒污染的风险低,还可冷冻保存后行自体移植。然而,脐血MSC的培养成功率不高[19, 23-24],Shetty 的研究认为只有6%,而脐带MSC的培养成功率可 达100%[25]。另外从脐血中分离MSC S ,就浪费了其中的造血干/祖细胞(hematopoietic stem cells/hematopoietic progenitor cells,HSCs/HPCs) [26, 27],因此,脐带MSC S (umbilical cord mesenchymal stem cells, UC-MSC S )就成 为重要来源。 一.概述 人脐带约40 g, 它的长度约60–65 cm, 足月脐带的平均直径约1.5 cm[28, 29]。脐带被覆着鳞状上皮,叫脐带上皮,是单层或复层结构,这层上皮由羊膜延续过来[30, 31]。脐带的内部是两根动脉和一根静脉,血管之间是粘液样的结缔组织,叫做沃顿胶质,充当血管外膜的功能。脐带中无毛细血管和淋巴系统。沃顿胶质的网状系统是糖蛋白微纤维和胶原纤维。沃顿胶质中最多的葡萄糖胺聚糖是透明质酸,它是包绕在成纤维样细胞和胶原纤维周围的并维持脐带形状的水合凝胶,使脐带免受挤压。沃顿胶质的基质细胞是成纤维样细胞[32],这种中间丝蛋白表达于间充质来源的细胞如成纤维细胞的,而不表达于平滑肌细胞。共表达波形蛋白和索蛋白提示这些细胞本质上肌纤维母细胞。 脐带基质细胞也是一种具有多能干细胞特点的细胞,具有多项分化潜能,其 形态和生物学特点与骨髓源性MSC S 相似[5, 20, 21, 38, 46],但脐带MSC S 更原始,是介 于成体干细胞和胚胎干细胞之间的一种干细胞,表达Oct-4, Sox-2和Nanog等多

英语演讲稿:未来的工作

英语演讲稿:未来的工作 这篇《英语演讲稿范文:未来的工作》,是特地,希望对大家有所帮助! 热门演讲推荐:竞聘演讲稿 | 国旗下演讲稿 | 英语演讲稿 | 师德师风演讲稿 | 年会主持词 | 领导致辞 everybody good afternoon:. first of all thank the teacher gave me a story in my own future ideal job. everyone has a dream job. my dream is to bee a boss, own a pany. in order to achieve my dreams, i need to find a good job, to accumulate some experience and wealth, it is the necessary things of course, in the school good achievement and rich knowledge is also very important. good achievement and rich experience can let me work to make the right choice, have more opportunities and achievements. at the same time, munication is very important, because it determines whether my pany has a good future development. so i need to exercise their municative ability. i need to use all of the free time to learn

最新小学生个人读书事迹简介怎么写800字

小学生个人读书事迹简介怎么写800字 书,是人类进步的阶梯,苏联作家高尔基的一句话道出了书的重要。书可谓是众多名人的“宠儿”。历来,名人说出关于书的名言数不胜数。今天小编在这给大家整理了小学生个人读书事迹,接下来随着小编一起来看看吧! 小学生个人读书事迹1 “万般皆下品,惟有读书高”、“书中自有颜如玉,书中自有黄金屋”,古往今来,读书的好处为人们所重视,有人“学而优则仕”,有人“满腹经纶”走上“传道授业解惑也”的道路……但是,从长远的角度看,笔者认为读书的好处在于增加了我们做事的成功率,改善了生活的质量。 三国时期的大将吕蒙,行伍出身,不重视文化的学习,行文时,常常要他人捉刀。经过主君孙权的劝导,吕蒙懂得了读书的重要性,从此手不释卷,成为了一代儒将,连东吴的智囊鲁肃都对他“刮目相待”。后来的事实证明,荆州之战的胜利,擒获“武圣”关羽,离不开吕蒙的“运筹帷幄,决胜千里”,而他的韬略离不开平时的读书。由此可见,一个人行事的成功率高低,与他的对读书,对知识的重视程度是密切相关的。 的物理学家牛顿曾近说过,“如果我比别人看得更远,那是因为我站在巨人的肩上”,鲜花和掌声面前,一代伟人没有迷失方向,自始至终对读书保持着热枕。牛顿的话语告诉我们,渊博的知识能让我们站在更高、更理性的角度来看问题,从而少犯错误,少走弯路。

读书的好处是显而易见的,但是,在社会发展日新月异的今天,依然不乏对读书,对知识缺乏认知的人,《今日说法》中我们反复看到农民工没有和用人单位签订劳动合同,最终讨薪无果;屠户不知道往牛肉里掺“巴西疯牛肉”是犯法的;某父母坚持“棍棒底下出孝子”,结果伤害了孩子的身心,也将自己送进了班房……对书本,对知识的零解读让他们付出了惨痛的代价,当他们奔波在讨薪的路上,当他们面对高墙电网时,幸福,从何谈起?高质量的生活,从何谈起? 读书,让我们体会到“锄禾日当午,汗滴禾下土”的艰辛;读书,让我们感知到“四海无闲田,农夫犹饿死”的无奈;读书,让我们感悟到“为报倾城随太守,西北望射天狼”的豪情壮志。 读书的好处在于提高了生活的质量,它填补了我们人生中的空白,让我们不至于在大好的年华里无所事事,从书本中,我们学会提炼出有用的信息,汲取成长所需的营养。所以,我们要认真读书,充分认识到读书对改善生活的重要意义,只有这样,才是一种负责任的生活态度。 小学生个人读书事迹2 所谓读一本好书就是交一个良师益友,但我认为读一本好书就是一次大冒险,大探究。一次体会书的过程,真的很有意思,咯咯的笑声,总是从书香里散发;沉思的目光也总是从书本里透露。是书给了我启示,是书填补了我无聊的夜空,也是书带我遨游整个古今中外。所以人活着就不能没有书,只要爱书你就是一个爱生活的人,只要爱书你就是一个大写的人,只要爱书你就是一个懂得珍惜与否的人。可真所谓

脐带血造血干细胞库管理办法(试行)

脐带血造血干细胞库管理办法(试行) 第一章总则 第一条为合理利用我国脐带血造血干细胞资源,促进脐带血造血干细胞移植高新技术的发展,确保脐带血 造血干细胞应用的安全性和有效性,特制定本管理办法。 第二条脐带血造血干细胞库是指以人体造血干细胞移植为目的,具有采集、处理、保存和提供造血干细胞 的能力,并具有相当研究实力的特殊血站。 任何单位和个人不得以营利为目的进行脐带血采供活动。 第三条本办法所指脐带血为与孕妇和新生儿血容量和血循环无关的,由新生儿脐带扎断后的远端所采集的 胎盘血。 第四条对脐带血造血干细胞库实行全国统一规划,统一布局,统一标准,统一规范和统一管理制度。 第二章设置审批 第五条国务院卫生行政部门根据我国人口分布、卫生资源、临床造血干细胞移植需要等实际情况,制订我 国脐带血造血干细胞库设置的总体布局和发展规划。 第六条脐带血造血干细胞库的设置必须经国务院卫生行政部门批准。 第七条国务院卫生行政部门成立由有关方面专家组成的脐带血造血干细胞库专家委员会(以下简称专家委

员会),负责对脐带血造血干细胞库设置的申请、验收和考评提出论证意见。专家委员会负责制订脐带血 造血干细胞库建设、操作、运行等技术标准。 第八条脐带血造血干细胞库设置的申请者除符合国家规划和布局要求,具备设置一般血站基本条件之外, 还需具备下列条件: (一)具有基本的血液学研究基础和造血干细胞研究能力; (二)具有符合储存不低于1 万份脐带血的高清洁度的空间和冷冻设备的设计规划; (三)具有血细胞生物学、HLA 配型、相关病原体检测、遗传学和冷冻生物学、专供脐带血处理等符合GMP、 GLP 标准的实验室、资料保存室; (四)具有流式细胞仪、程控冷冻仪、PCR 仪和细胞冷冻及相关检测及计算机网络管理等仪器设备; (五)具有独立开展实验血液学、免疫学、造血细胞培养、检测、HLA 配型、病原体检测、冷冻生物学、 管理、质量控制和监测、仪器操作、资料保管和共享等方面的技术、管理和服务人员; (六)具有安全可靠的脐带血来源保证; (七)具备多渠道筹集建设资金运转经费的能力。 第九条设置脐带血造血干细胞库应向所在地省级卫生行政部门提交设置可行性研究报告,内容包括:

关于坚持的英语演讲稿

关于坚持的英语演讲稿 Results are not important, but they can persist for many years as a commemoration of. Many years ago, as a result of habits and overeating formed one of obesity, as well as indicators of overall physical disorders, so that affects my work and life. In friends to encourage and supervise, the participated in the team Now considered to have been more than three years, neither the fine rain, regardless of winter heat, a day out with 5:00 time. The beginning, have been discouraged, suffering, and disappointment, but in the end of the urging of friends, to re-get up, stand on the playground. 成绩并不重要,但可以作为坚持多年晨跑的一个纪念。多年前,由于庸懒习惯和暴饮暴食,形成了一身的肥胖,以及体检指标的全盘失常,以致于影响到了我的工作和生活。在好友的鼓励和督促下,参加了晨跑队伍。现在算来,已经三年多了,无论天晴下雨,不管寒冬酷暑,每天五点准时起来出门晨跑。开始时,也曾气馁过、痛苦过、失望过,但最后都在好友们的催促下,重新爬起来,站到了操场上。 In fact, I did not build big, nor strong muscles, not a sport-born people. Over the past few years to adhere to it, because I have a team behind, the strength of a strongteam here, very grateful to our team, for a long time, we encourage each other, and with sweat, enjoying common health happy. For example, Friends of the several run in order to maintain order and unable to attend the 10,000 meters race, and they are always concerned about the brothers and promptly inform the place and time, gives us confidence and courage. At the same time, also came on their own inner desire and pursuit for a good health, who wrote many of their own log in order to refuel for their own, and inspiring. 其实我没有高大身材,也没健壮肌肉,天生不属于运动型的人。几年来能够坚持下来,因为我的背后有一个团队,有着强大团队的力量,在这里,非常感谢我们的晨跑队,长期以来,我们相互鼓励着,一起流汗,共同享受着健康带来的快

关于管理的英语演讲

1.How to build a business that lasts100years 0:11Imagine that you are a product designer.And you've designed a product,a new type of product,called the human immune system.You're pitching this product to a skeptical,strictly no-nonsense manager.Let's call him Bob.I think we all know at least one Bob,right?How would that go? 0:34Bob,I've got this incredible idea for a completely new type of personal health product.It's called the human immune system.I can see from your face that you're having some problems with this.Don't worry.I know it's very complicated.I don't want to take you through the gory details,I just want to tell you about some of the amazing features of this product.First of all,it cleverly uses redundancy by having millions of copies of each component--leukocytes,white blood cells--before they're actually needed,to create a massive buffer against the unexpected.And it cleverly leverages diversity by having not just leukocytes but B cells,T cells,natural killer cells,antibodies.The components don't really matter.The point is that together,this diversity of different approaches can cope with more or less anything that evolution has been able to throw up.And the design is completely modular.You have the surface barrier of the human skin,you have the very rapidly reacting innate immune system and then you have the highly targeted adaptive immune system.The point is,that if one system fails,another can take over,creating a virtually foolproof system. 1:54I can see I'm losing you,Bob,but stay with me,because here is the really killer feature.The product is completely adaptive.It's able to actually develop targeted antibodies to threats that it's never even met before.It actually also does this with incredible prudence,detecting and reacting to every tiny threat,and furthermore, remembering every previous threat,in case they are ever encountered again.What I'm pitching you today is actually not a stand-alone product.The product is embedded in the larger system of the human body,and it works in complete harmony with that system,to create this unprecedented level of biological protection.So Bob,just tell me honestly,what do you think of my product? 2:47And Bob may say something like,I sincerely appreciate the effort and passion that have gone into your presentation,blah blah blah-- 2:56(Laughter) 2:58But honestly,it's total nonsense.You seem to be saying that the key selling points of your product are that it is inefficient and complex.Didn't they teach you 80-20?And furthermore,you're saying that this product is siloed.It overreacts, makes things up as it goes along and is actually designed for somebody else's benefit. I'm sorry to break it to you,but I don't think this one is a winner.

关于工作的优秀英语演讲稿

关于工作的优秀英语演讲稿 Different people have various ambitions. Some want to be engineers or doctors in the future. Some want to be scientists or businessmen. Still some wish to be teachers or lawers when they grow up in the days to come. Unlike other people, I prefer to be a farmer. However, it is not easy to be a farmer for Iwill be looked upon by others. Anyway,what I am trying to do is to make great contributions to agriculture. It is well known that farming is the basic of the country. Above all, farming is not only a challenge but also a good opportunity for the young. We can also make a big profit by growing vegetables and food in a scientific way. Besides we can apply what we have learned in school to farming. Thus our countryside will become more and more properous. I believe that any man with knowledge can do whatever they can so long as this job can meet his or her interest. All the working position can provide him with a good chance to become a talent. 1 ————来源网络整理,仅供供参考

个人先进事迹简介

个人先进事迹简介 01 在思想政治方面,xxxx同学积极向上,热爱祖国、热爱中国共产党,拥护中国共产党的领导.利用课余时间和党课机会认真学习政治理论,积极向党组织靠拢. 在学习上,xxxx同学认为只有把学习成绩确实提高才能为将来的实践打下扎实的基础,成为社会有用人才.学习努力、成绩优良. 在生活中,善于与人沟通,乐观向上,乐于助人.有健全的人格意识和良好的心理素质和从容、坦诚、乐观、快乐的生活态度,乐于帮助身边的同学,受到师生的好评. 02 xxx同学认真学习政治理论,积极上进,在校期间获得原院级三好生,和校级三好生,优秀团员称号,并获得三等奖学金. 在学习上遇到不理解的地方也常常向老师请教,还勇于向老师提出质疑.在完成自己学业的同时,能主动帮助其他同学解决学习上的难题,和其他同学共同探讨,共同进步. 在社会实践方面,xxxx同学参与了中国儿童文学精品“悦”读书系,插画绘制工作,xxxx同学在班中担任宣传委员,工作积极主动,认真负责,有较强的组织能力.能够在老师、班主任的指导下独立完成学院、班级布置的各项工作. 03 xxx同学在政治思想方面积极进取,严格要求自己.在学习方面刻苦努力,不断钻研,学习成绩优异,连续两年荣获国家励志奖学金;作

为一名学生干部,她总是充满激情的迎接并完成各项工作,荣获优秀团干部称号.在社会实践和志愿者活动中起到模范带头作用. 04 xxxx同学在思想方面,积极要求进步,为人诚实,尊敬师长.严格 要求自己.在大一期间就积极参加了党课初、高级班的学习,拥护中国共产党的领导,并积极向党组织靠拢. 在工作上,作为班中的学习委员,对待工作兢兢业业、尽职尽责 的完成班集体的各项工作任务.并在班级和系里能够起骨干带头作用.热心为同学服务,工作责任心强. 在学习上,学习目的明确、态度端正、刻苦努力,连续两学年在 班级的综合测评排名中获得第1.并荣获院级二等奖学金、三好生、优秀班干部、优秀团员等奖项. 在社会实践方面,积极参加学校和班级组织的各项政治活动,并 在志愿者活动中起到模范带头作用.积极锻炼身体.能够处理好学习与工作的关系,乐于助人,团结班中每一位同学,谦虚好学,受到师生的好评. 05 在思想方面,xxxx同学积极向上,热爱祖国、热爱中国共产党,拥护中国共产党的领导.作为一名共产党员时刻起到积极的带头作用,利用课余时间和党课机会认真学习政治理论. 在工作上,作为班中的团支部书记,xxxx同学积极策划组织各类 团活动,具有良好的组织能力. 在学习上,xxxx同学学习努力、成绩优良、并热心帮助在学习上有困难的同学,连续两年获得二等奖学金. 在生活中,善于与人沟通,乐观向上,乐于助人.有健全的人格意 识和良好的心理素质.

自我管理演讲稿英语翻译

尊敬的领导,老师,亲爱的同学们, 大家好!我是5班的梁浩东。今天早上我坐车来学校的路上,我仔细观察了路上形形色色的人,有开着小车衣着精致的叔叔阿姨,有市场带着倦容的卖各种早点的阿姨,还有偶尔穿梭于人群中衣衫褴褛的乞丐。于是我问自己,十几年后我会成为怎样的自己,想成为社会成功人士还是碌碌无为的人呢,答案肯定是前者。那么十几年后我怎样才能如愿以偿呢,成为一个受人尊重,有价值的人呢?正如我今天演讲的题目是:自主管理。 大家都知道爱玩是我们孩子的天性,学习也是我们的责任和义务。要怎样处理好这些矛盾,提高自主管理呢? 首先,我们要有小主人翁思想,自己做自己的主人,要认识到我们学习,生活这一切都是我们自己走自己的人生路,并不是为了报答父母,更不是为了敷衍老师。 我认为自主管理又可以理解为自我管理,在学习和生活中无处不在,比如通过老师,小组长来管理约束行为和同学们对自身行为的管理都属于自我管理。比如我们到一个旅游景点,看到一块大石头,有的同学特别兴奋,会想在上面刻上:某某某到此一游话。这时你就需要自我管理,你需要提醒自己,这样做会破坏景点,而且是一种素质低下的表现。你设想一下,如果别人家小孩去你家墙上乱涂乱画,你是何种感受。同样我们把自主管理放到学习上,在我们想偷懒,想逃避,想放弃的时候,我们可以通过自主管理来避免这些,通过他人或者自己的力量来完成。例如我会制定作息时间计划表,里面包括学习,运动,玩耍等内容的完成时间。那些学校学习尖子,他们学习好是智商高于我们吗,其实不然,在我所了解的哪些优秀的学霸传授经验里,就提到要能够自我管理,规范好学习时间的分分秒秒,只有辛勤的付出,才能取得优异成绩。 在现实生活中,无数成功人士告诉我们自主管理的重要性。十几年后我想成为一位优秀的,为国家多做贡献的人。亲爱的同学们,你们们?让我们从现在开始重视和执行自主管理,十几年后成为那个你想成为的人。 谢谢大家!

关于工作的英语演讲稿

关于工作的英语演讲稿 【篇一:关于工作的英语演讲稿】 关于工作的英语演讲稿 different people have various ambitions. some want to be engineers or doctors in the future. some want to be scientists or businessmen. still some wish to be teachers or lawers when they grow up in the days to come. unlike other people, i prefer to be a farmer. however, it is not easy to be a farmer for iwill be looked upon by others. anyway,what i am trying to do is to make great contributions to agriculture. it is well known that farming is the basic of the country. above all, farming is not only a challenge but also a good opportunity for the young. we can also make a big profit by growing vegetables and food in a scientific way. besides we can apply what we have learned in school to farming. thus our countryside will become more and more properous. i believe that any man with knowledge can do whatever they can so long as this job can meet his or her interest. all the working position can provide him with a good chance to become a talent. 【篇二:关于责任感的英语演讲稿】 im grateful that ive been given this opportunity to stand here as a spokesman. facing all of you on the stage, i have the exciting feeling of participating in this speech competition. the topic today is what we cannot afford to lose. if you ask me this question, i must tell you that i think the answer is a word---- responsibility. in my elementary years, there was a little girl in the class who worked very hard, however she could never do satisfactorily in her lessons. the teacher asked me to help her, and it was obvious that she expected a lot from me. but as a young boy, i was so restless and thoughtless, i always tried to get more time to play and enjoy myself. so she was always slighted over by me. one day before the final exam, she came up to me and said, could you please explain this to me? i can not understand it. i

关于时间管理的英语演讲

Dear teacher and colleagues: my topic is on “spare time”. It is a huge blessing that we can work 996. Jack Ma said at an Ali's internal communication activity, That means we should work at 9am to 9pm, 6 days a week .I question the entire premise of this piece. but I'm always interested in hearing what successful and especially rich people come up with time .So I finally found out Jack Ma also had said :”i f you don’t put out more time and energy than others ,how can you achieve the success you want? If you do not do 996 when you are young ,when will you ?”I quite agree with the idea that young people should fight for success .But there are a lot of survival activities to do in a day ,I want to focus on how much time they take from us and what can we do with the rest of the time. As all we known ,There are 168 hours in a week .We sleep roughly seven-and-a-half and eight hours a day .so around 56 hours a week . maybe it is slightly different for someone . We do our personal things like eating and bathing and maybe looking after kids -about three hours a day .so around 21 hours a week .And if you are working a full time job ,so 40 hours a week , Oh! Maybe it is impossible for us at

卫生部办公厅关于印发《脐带血造血干细胞治疗技术管理规范(试行)

卫生部办公厅关于印发《脐带血造血干细胞治疗技术管理规 范(试行)》的通知 【法规类别】采供血机构和血液管理 【发文字号】卫办医政发[2009]189号 【失效依据】国家卫生计生委办公厅关于印发造血干细胞移植技术管理规范(2017年版)等15个“限制临床应用”医疗技术管理规范和质量控制指标的通知 【发布部门】卫生部(已撤销) 【发布日期】2009.11.13 【实施日期】2009.11.13 【时效性】失效 【效力级别】部门规范性文件 卫生部办公厅关于印发《脐带血造血干细胞治疗技术管理规范(试行)》的通知 (卫办医政发〔2009〕189号) 各省、自治区、直辖市卫生厅局,新疆生产建设兵团卫生局: 为贯彻落实《医疗技术临床应用管理办法》,做好脐带血造血干细胞治疗技术审核和临床应用管理,保障医疗质量和医疗安全,我部组织制定了《脐带血造血干细胞治疗技术管理规范(试行)》。现印发给你们,请遵照执行。 二〇〇九年十一月十三日

脐带血造血干细胞 治疗技术管理规范(试行) 为规范脐带血造血干细胞治疗技术的临床应用,保证医疗质量和医疗安全,制定本规范。本规范为技术审核机构对医疗机构申请临床应用脐带血造血干细胞治疗技术进行技术审核的依据,是医疗机构及其医师开展脐带血造血干细胞治疗技术的最低要求。 本治疗技术管理规范适用于脐带血造血干细胞移植技术。 一、医疗机构基本要求 (一)开展脐带血造血干细胞治疗技术的医疗机构应当与其功能、任务相适应,有合法脐带血造血干细胞来源。 (二)三级综合医院、血液病医院或儿童医院,具有卫生行政部门核准登记的血液内科或儿科专业诊疗科目。 1.三级综合医院血液内科开展成人脐带血造血干细胞治疗技术的,还应当具备以下条件: (1)近3年内独立开展脐带血造血干细胞和(或)同种异基因造血干细胞移植15例以上。 (2)有4张床位以上的百级层流病房,配备病人呼叫系统、心电监护仪、电动吸引器、供氧设施。 (3)开展儿童脐带血造血干细胞治疗技术的,还应至少有1名具有副主任医师以上专业技术职务任职资格的儿科医师。 2.三级综合医院儿科开展儿童脐带血造血干细胞治疗技术的,还应当具备以下条件:

相关主题